Strensiq 100 mg (Asfotase Alfa SOLUTION) 100 MG

STRENSIQ 100 MG is a subcutaneous solution containing asfotase alfa, used for managing hypophosphatasia. This enzyme replacement therapy is designed to address bone mineralization issues. Learn more about its uses and effects.

Strength

100 MG

Manufacturer / TM Owner

ALEXION PHARMA GMBH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

STRENSIQ 100 MG is primarily used for the treatment of hypophosphatasia, a rare genetic disorder that affects bone mineralization. Asfotase alfa, the active ingredient, works by replacing the deficient enzyme, helping to improve bone health and function. Patients often seek information on what is STRENSIQ used for, particularly in managing symptoms related to bone fragility and growth issues.

Side Effects

Common effects of STRENSIQ 100 MG may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience systemic effects like fever or fatigue. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

STRENSIQ 100 MG should be handled with care, ensuring proper storage and administration as directed. It is important to follow the prescribed dosage and administration guidelines to minimize the risk of adverse effects. Always consult a healthcare professional before starting or stopping any medication.

Avoid Interactions

STRENSIQ 100 MG may interact with other medications or substances, so it is crucial to inform your healthcare provider about all current medications. Alcohol and certain foods might also affect its efficacy. Always discuss potential interactions with a healthcare professional.

Frequently Asked Questions

STRENSIQ is used to treat hypophosphatasia, a genetic disorder that affects bone mineralization.

STRENSIQ is administered via subcutaneous injection, typically at home after proper training.

Common side effects include injection site reactions, fever, and fatigue.

Potential interactions should be discussed with a healthcare provider to ensure safety.

STRENSIQ should be stored as directed, typically in a refrigerator, to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.